Sample Collection for Ongoing Research and Product Evaluation Study - Non-muscle Invasive Bladder Cancer (SCORE-NMIBC)

← catalyst calendar

NCT07763197 · readout ≤ 2,172 d

Sponsored by Natera, Inc. (industry) · NTRA — their whole pipeline →.

Phase

—

Status

Recruiting

Study type

Observational

Enrollment

400estimated

Sites

Country

United States

Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →

Source: ClinicalTrials.gov, retrieved 2026-08-19

Dates

each axis at the precision it was filed, with the registry's own basis

Date

Filed

Basis

What it is

Start

2026-07-27

estimated

When the study began enrolling

Primary completion

Jul 2032

estimated

The date the last participant is measured for the primary outcome — the readout window

Study completion

Jul 2032

estimated

The whole study's end, after follow-up

First posted

2026-08-13

actual

When this record first appeared on the registry

Results posted

—

When the sponsor posted results to the registry

Record updated

2026-08-13

actual

The sponsor's own last edit to this record — every projection above is as current as this date

What it studies

Conditions

Non-Muscle Invasive Bladder Cancer
NMIBC
High-risk Non-Muscle Invasive Bladder Cancer

Primary outcome

what the primary-completion date above is the date OF

Number of Completed Participants with Blood, Urine and Residual Tissue Specimens Collected

measured 3 Years

Permalink · NTRA's whole pipeline · Catalyst calendar · Every registered study · What changed